hepatitis-c

Documents about hepatitis-c

• A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney Transplantation#907925ClinicalTrials.gov
• Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation.#1365NCBI PubMed Central
• Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022#149912Unpaywall
• Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis#833652ClinicalTrials.gov
• Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease#843227ClinicalTrials.gov
• Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.#846563ClinicalTrials.gov
• Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)#846947ClinicalTrials.gov
• DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject Drugs#855440ClinicalTrials.gov
• Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection#863329ClinicalTrials.gov
• Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment#881570ClinicalTrials.gov
• Intervention to Reduce Injection Drug Use#893999ClinicalTrials.gov
• Evaluation of Dried Blood Spot for HCV RNA Testing#1031197ClinicalTrials.gov
• Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)#1047640ClinicalTrials.gov
• Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m#847212ClinicalTrials.gov
• Frequent Longitudinal Sampling of Hepatitis C Virus Infection in Injection Drug Users Reveals Intermittently Detectable Viremia and Reinfection#642252eScholarship
• WHO technical report on monitoring timepoints in adult patients treated for HCV with pegylated interferon alpha and ribavirin#627345WHO IRIS
• PICO 1: testing: a systematic review and meta-analysis of targeted HCV antibody testing interventions#627347WHO IRIS
• A study protocol for co-designing risk communication strategies for hepatitis C virus (HCV) testing among priority populations in Johannesburg district, Gauteng, South Africa.#662583NCBI PubMed Central
• Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients#858515ClinicalTrials.gov
• The Efficacy of Vosevi in Treating DAA-experienced Patients#888317ClinicalTrials.gov
• 3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals#891717ClinicalTrials.gov
• Directly Observed Therapy for HCV in Chennai, India#898951ClinicalTrials.gov
• A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir#969835ClinicalTrials.gov
• MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo#803098ClinicalTrials.gov
• Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities#348440PubMed Central
• Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study.#462138Repisalud
• Interpersonal Dynamics and Health Behaviors among People who Inject Drugs#651666eScholarship
• HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b#841154ClinicalTrials.gov
• A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients#870290ClinicalTrials.gov
• Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma#881022ClinicalTrials.gov
• Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325#904855ClinicalTrials.gov
• Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection#912911ClinicalTrials.gov
• Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)#1031443ClinicalTrials.gov
• Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis#20052DOAJ
• Impact of fatigue on patient-reported outcomes and work productivity in chronic hepatitis b and c: insights from a multinational registry study#263370Recep Tayyip Erdoğan University Institutional Repository
• HEPATITIS C SCREENING AND TREATMENT IN VICTORIAN PUBLIC MENTAL HEALTH SETTINGS: TIME FOR ACTION#448638Figshare
• Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients#837841ClinicalTrials.gov
• A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies#861338ClinicalTrials.gov
• Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection#1032767ClinicalTrials.gov
• Analyse des Einflusses von seltenen Codons auf das „Ribosome Pausing“ und die Effizienz der Translation und Replikation des Hepatitis C Virus#367552JLUpub
• Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection#830596ClinicalTrials.gov
• Injecting Drug Use Community Intervention Trial#858313ClinicalTrials.gov
• Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant#908637ClinicalTrials.gov
• Injecting drug use worsens the quality of life in HIV-HCV co-infected patients in Vietnam#257620HAL (France)
• Performance characteristics of an electronic medical record alert system to identify hospitalised patients with active hepatitis C virus infection: a cross-sectional analysis from two large academic centres.#645390NCBI PubMed Central
• Pooled prevalence, risk factors and barriers to care for hepatitis C virus (HCV) in adults with serious mental illness (SMI): an updated systematic review and meta-analysis - protocol.#670915NCBI PubMed Central
• Study of HIV, HCV, APS and Phylogenetics for PWID#852470ClinicalTrials.gov
• Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum#880996ClinicalTrials.gov
• HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment#898110ClinicalTrials.gov
• Efficacy and Safety of Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir Tablets for the Treatment of Chronic HCV Infection: A Prospective, Multi-center Real-world Study.#968146ClinicalTrials.gov